🕵️ Cumberland Pharmaceuticals Inc ($CPIX)
SEC insider & ownership activity, last 12 months · CIK 1087294 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. A.j. Kazimi trimmed 40.8% → 38.4%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| A.j. Kazimi | 38.4% | 13G | Feb 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Aug 28, 2026 | filing ↗ |
| Earnings (2.02) | Aug 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2026 | filing ↗ |
| Other events (8.01) | Jul 13, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 29, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jun 29, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Other events (8.01) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 24, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 22, 2026 | filing ↗ |
| Other events (8.01) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 21, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Other events (8.01) | Feb 4, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 18, 2025 | filing ↗ |
| New financial obligation (2.03) | Nov 18, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Other events (8.01) | Oct 21, 2025 | filing ↗ |